Supplemental Figure from A Multicenter, Phase II, Randomized, Noncomparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly Diagnosed Glioblastoma Patients Article Swipe
Eudocia Q. Lee
,
Thomas Kaley
,
Dan G. Duda
,
David Schiff
,
Andrew B. Lassman
,
Eric T. Wong
,
Tom Mikkelsen
,
Benjamin Purow
,
Alona Muzikansky
,
Marek Ancukiewicz
,
Jason T. Huse
,
Shakti Ramkissoon
,
Jan Drappatz
,
Andrew D. Norden
,
Rameen Beroukhim
,
Stephanie E. Weiss
,
Brian M. Alexander
,
Christine McCluskey
,
Mary Gerard
,
Katrina H. Smith
,
Rakesh K. Jain
,
Tracy T. Batchelor
,
Keith L. Ligon
,
Patrick Y. Wen
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/1078-0432.22456728
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/1078-0432.22456728
Supplemental Figure: Mean plasma concentrations of vandetanib.
Related Topics
Concepts
Metadata
- Type
- preprint
- Language
- en
- Landing Page
- https://doi.org/10.1158/1078-0432.22456728
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4362396134
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4362396134Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1158/1078-0432.22456728Digital Object Identifier
- Title
-
Supplemental Figure from A Multicenter, Phase II, Randomized, Noncomparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly Diagnosed Glioblastoma PatientsWork title
- Type
-
preprintOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-03-31Full publication date if available
- Authors
-
Eudocia Q. Lee, Thomas Kaley, Dan G. Duda, David Schiff, Andrew B. Lassman, Eric T. Wong, Tom Mikkelsen, Benjamin Purow, Alona Muzikansky, Marek Ancukiewicz, Jason T. Huse, Shakti Ramkissoon, Jan Drappatz, Andrew D. Norden, Rameen Beroukhim, Stephanie E. Weiss, Brian M. Alexander, Christine McCluskey, Mary Gerard, Katrina H. Smith, Rakesh K. Jain, Tracy T. Batchelor, Keith L. Ligon, Patrick Y. WenList of authors in order
- Landing page
-
https://doi.org/10.1158/1078-0432.22456728Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1158/1078-0432.22456728Direct OA link when available
- Concepts
-
Vandetanib, Temozolomide, Medicine, Glioblastoma, Internal medicine, Clinical trial, Oncology, Phases of clinical research, Multicenter trial, Randomized controlled trial, Radiation therapy, Nuclear medicine, Multicenter study, Cancer research, Tyrosine kinase, ReceptorTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4362396134 |
|---|---|
| doi | https://doi.org/10.1158/1078-0432.22456728 |
| ids.doi | https://doi.org/10.1158/1078-0432.22456728 |
| ids.openalex | https://openalex.org/W4362396134 |
| fwci | |
| type | preprint |
| title | Supplemental Figure from A Multicenter, Phase II, Randomized, Noncomparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly Diagnosed Glioblastoma Patients |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T11395 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9962999820709229 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2741 |
| topics[0].subfield.display_name | Radiology, Nuclear Medicine and Imaging |
| topics[0].display_name | Radiopharmaceutical Chemistry and Applications |
| topics[1].id | https://openalex.org/T10129 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9848999977111816 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2716 |
| topics[1].subfield.display_name | Genetics |
| topics[1].display_name | Glioma Diagnosis and Treatment |
| topics[2].id | https://openalex.org/T10522 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9829999804496765 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2741 |
| topics[2].subfield.display_name | Radiology, Nuclear Medicine and Imaging |
| topics[2].display_name | Medical Imaging Techniques and Applications |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2780333294 |
| concepts[0].level | 4 |
| concepts[0].score | 0.9809589982032776 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q7914515 |
| concepts[0].display_name | Vandetanib |
| concepts[1].id | https://openalex.org/C2777389519 |
| concepts[1].level | 3 |
| concepts[1].score | 0.8940349817276001 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q425088 |
| concepts[1].display_name | Temozolomide |
| concepts[2].id | https://openalex.org/C71924100 |
| concepts[2].level | 0 |
| concepts[2].score | 0.6417611837387085 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[2].display_name | Medicine |
| concepts[3].id | https://openalex.org/C2776194525 |
| concepts[3].level | 2 |
| concepts[3].score | 0.5788504481315613 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q282142 |
| concepts[3].display_name | Glioblastoma |
| concepts[4].id | https://openalex.org/C126322002 |
| concepts[4].level | 1 |
| concepts[4].score | 0.5213392972946167 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[4].display_name | Internal medicine |
| concepts[5].id | https://openalex.org/C535046627 |
| concepts[5].level | 2 |
| concepts[5].score | 0.494759738445282 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q30612 |
| concepts[5].display_name | Clinical trial |
| concepts[6].id | https://openalex.org/C143998085 |
| concepts[6].level | 1 |
| concepts[6].score | 0.4760294258594513 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[6].display_name | Oncology |
| concepts[7].id | https://openalex.org/C31760486 |
| concepts[7].level | 3 |
| concepts[7].score | 0.45802271366119385 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q7180990 |
| concepts[7].display_name | Phases of clinical research |
| concepts[8].id | https://openalex.org/C2775965419 |
| concepts[8].level | 4 |
| concepts[8].score | 0.4511512815952301 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q6934595 |
| concepts[8].display_name | Multicenter trial |
| concepts[9].id | https://openalex.org/C168563851 |
| concepts[9].level | 2 |
| concepts[9].score | 0.42078065872192383 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q1436668 |
| concepts[9].display_name | Randomized controlled trial |
| concepts[10].id | https://openalex.org/C509974204 |
| concepts[10].level | 2 |
| concepts[10].score | 0.39681071043014526 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q180507 |
| concepts[10].display_name | Radiation therapy |
| concepts[11].id | https://openalex.org/C2989005 |
| concepts[11].level | 1 |
| concepts[11].score | 0.32263457775115967 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q214963 |
| concepts[11].display_name | Nuclear medicine |
| concepts[12].id | https://openalex.org/C2992435398 |
| concepts[12].level | 3 |
| concepts[12].score | 0.3126765489578247 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q6934595 |
| concepts[12].display_name | Multicenter study |
| concepts[13].id | https://openalex.org/C502942594 |
| concepts[13].level | 1 |
| concepts[13].score | 0.18327346444129944 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q3421914 |
| concepts[13].display_name | Cancer research |
| concepts[14].id | https://openalex.org/C42362537 |
| concepts[14].level | 3 |
| concepts[14].score | 0.06305938959121704 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q87099740 |
| concepts[14].display_name | Tyrosine kinase |
| concepts[15].id | https://openalex.org/C170493617 |
| concepts[15].level | 2 |
| concepts[15].score | 0.05548584461212158 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q208467 |
| concepts[15].display_name | Receptor |
| keywords[0].id | https://openalex.org/keywords/vandetanib |
| keywords[0].score | 0.9809589982032776 |
| keywords[0].display_name | Vandetanib |
| keywords[1].id | https://openalex.org/keywords/temozolomide |
| keywords[1].score | 0.8940349817276001 |
| keywords[1].display_name | Temozolomide |
| keywords[2].id | https://openalex.org/keywords/medicine |
| keywords[2].score | 0.6417611837387085 |
| keywords[2].display_name | Medicine |
| keywords[3].id | https://openalex.org/keywords/glioblastoma |
| keywords[3].score | 0.5788504481315613 |
| keywords[3].display_name | Glioblastoma |
| keywords[4].id | https://openalex.org/keywords/internal-medicine |
| keywords[4].score | 0.5213392972946167 |
| keywords[4].display_name | Internal medicine |
| keywords[5].id | https://openalex.org/keywords/clinical-trial |
| keywords[5].score | 0.494759738445282 |
| keywords[5].display_name | Clinical trial |
| keywords[6].id | https://openalex.org/keywords/oncology |
| keywords[6].score | 0.4760294258594513 |
| keywords[6].display_name | Oncology |
| keywords[7].id | https://openalex.org/keywords/phases-of-clinical-research |
| keywords[7].score | 0.45802271366119385 |
| keywords[7].display_name | Phases of clinical research |
| keywords[8].id | https://openalex.org/keywords/multicenter-trial |
| keywords[8].score | 0.4511512815952301 |
| keywords[8].display_name | Multicenter trial |
| keywords[9].id | https://openalex.org/keywords/randomized-controlled-trial |
| keywords[9].score | 0.42078065872192383 |
| keywords[9].display_name | Randomized controlled trial |
| keywords[10].id | https://openalex.org/keywords/radiation-therapy |
| keywords[10].score | 0.39681071043014526 |
| keywords[10].display_name | Radiation therapy |
| keywords[11].id | https://openalex.org/keywords/nuclear-medicine |
| keywords[11].score | 0.32263457775115967 |
| keywords[11].display_name | Nuclear medicine |
| keywords[12].id | https://openalex.org/keywords/multicenter-study |
| keywords[12].score | 0.3126765489578247 |
| keywords[12].display_name | Multicenter study |
| keywords[13].id | https://openalex.org/keywords/cancer-research |
| keywords[13].score | 0.18327346444129944 |
| keywords[13].display_name | Cancer research |
| keywords[14].id | https://openalex.org/keywords/tyrosine-kinase |
| keywords[14].score | 0.06305938959121704 |
| keywords[14].display_name | Tyrosine kinase |
| keywords[15].id | https://openalex.org/keywords/receptor |
| keywords[15].score | 0.05548584461212158 |
| keywords[15].display_name | Receptor |
| language | en |
| locations[0].id | doi:10.1158/1078-0432.22456728 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.1158/1078-0432.22456728 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5089730968 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Eudocia Q. Lee |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Eudocia Q. Lee |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5042155392 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-2540-8518 |
| authorships[1].author.display_name | Thomas Kaley |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Thomas J. Kaley |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5022702941 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-7065-8797 |
| authorships[2].author.display_name | Dan G. Duda |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Dan G. Duda |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5023905352 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | David Schiff |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | David Schiff |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5057541817 |
| authorships[4].author.orcid | https://orcid.org/0000-0001-7386-9928 |
| authorships[4].author.display_name | Andrew B. Lassman |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Andrew B. Lassman |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5047993679 |
| authorships[5].author.orcid | https://orcid.org/0000-0001-7112-6207 |
| authorships[5].author.display_name | Eric T. Wong |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Eric T. Wong |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5069699492 |
| authorships[6].author.orcid | https://orcid.org/0000-0001-6285-2442 |
| authorships[6].author.display_name | Tom Mikkelsen |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Tom Mikkelsen |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5076042525 |
| authorships[7].author.orcid | https://orcid.org/0000-0001-7372-6062 |
| authorships[7].author.display_name | Benjamin Purow |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Benjamin W. Purow |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5013091949 |
| authorships[8].author.orcid | https://orcid.org/0000-0001-7585-8181 |
| authorships[8].author.display_name | Alona Muzikansky |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Alona Muzikansky |
| authorships[8].is_corresponding | False |
| authorships[9].author.id | https://openalex.org/A5048844031 |
| authorships[9].author.orcid | |
| authorships[9].author.display_name | Marek Ancukiewicz |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Marek Ancukiewicz |
| authorships[9].is_corresponding | False |
| authorships[10].author.id | https://openalex.org/A5102859495 |
| authorships[10].author.orcid | https://orcid.org/0000-0003-4440-3250 |
| authorships[10].author.display_name | Jason T. Huse |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Jason T. Huse |
| authorships[10].is_corresponding | False |
| authorships[11].author.id | https://openalex.org/A5022385078 |
| authorships[11].author.orcid | |
| authorships[11].author.display_name | Shakti Ramkissoon |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Shakti Ramkissoon |
| authorships[11].is_corresponding | False |
| authorships[12].author.id | https://openalex.org/A5091053515 |
| authorships[12].author.orcid | https://orcid.org/0000-0001-8187-7119 |
| authorships[12].author.display_name | Jan Drappatz |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Jan Drappatz |
| authorships[12].is_corresponding | False |
| authorships[13].author.id | https://openalex.org/A5029013340 |
| authorships[13].author.orcid | |
| authorships[13].author.display_name | Andrew D. Norden |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Andrew D. Norden |
| authorships[13].is_corresponding | False |
| authorships[14].author.id | https://openalex.org/A5041980697 |
| authorships[14].author.orcid | https://orcid.org/0000-0001-6303-3609 |
| authorships[14].author.display_name | Rameen Beroukhim |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Rameen Beroukhim |
| authorships[14].is_corresponding | False |
| authorships[15].author.id | https://openalex.org/A5009505942 |
| authorships[15].author.orcid | https://orcid.org/0000-0003-2365-4296 |
| authorships[15].author.display_name | Stephanie E. Weiss |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Stephanie E. Weiss |
| authorships[15].is_corresponding | False |
| authorships[16].author.id | https://openalex.org/A5047888321 |
| authorships[16].author.orcid | https://orcid.org/0000-0003-3903-9175 |
| authorships[16].author.display_name | Brian M. Alexander |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | Brian M. Alexander |
| authorships[16].is_corresponding | False |
| authorships[17].author.id | https://openalex.org/A5111785291 |
| authorships[17].author.orcid | https://orcid.org/0000-0001-5610-8115 |
| authorships[17].author.display_name | Christine McCluskey |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | Christine S. McCluskey |
| authorships[17].is_corresponding | False |
| authorships[18].author.id | https://openalex.org/A5112095475 |
| authorships[18].author.orcid | |
| authorships[18].author.display_name | Mary Gerard |
| authorships[18].author_position | middle |
| authorships[18].raw_author_name | Mary Gerard |
| authorships[18].is_corresponding | False |
| authorships[19].author.id | https://openalex.org/A5072417567 |
| authorships[19].author.orcid | |
| authorships[19].author.display_name | Katrina H. Smith |
| authorships[19].author_position | middle |
| authorships[19].raw_author_name | Katrina H. Smith |
| authorships[19].is_corresponding | False |
| authorships[20].author.id | https://openalex.org/A5015585176 |
| authorships[20].author.orcid | https://orcid.org/0000-0001-7571-3548 |
| authorships[20].author.display_name | Rakesh K. Jain |
| authorships[20].author_position | middle |
| authorships[20].raw_author_name | Rakesh K. Jain |
| authorships[20].is_corresponding | False |
| authorships[21].author.id | https://openalex.org/A5069527451 |
| authorships[21].author.orcid | https://orcid.org/0000-0001-7568-6607 |
| authorships[21].author.display_name | Tracy T. Batchelor |
| authorships[21].author_position | middle |
| authorships[21].raw_author_name | Tracy T. Batchelor |
| authorships[21].is_corresponding | False |
| authorships[22].author.id | https://openalex.org/A5010270402 |
| authorships[22].author.orcid | https://orcid.org/0000-0002-7733-600X |
| authorships[22].author.display_name | Keith L. Ligon |
| authorships[22].author_position | middle |
| authorships[22].raw_author_name | Keith L. Ligon |
| authorships[22].is_corresponding | False |
| authorships[23].author.id | https://openalex.org/A5021656597 |
| authorships[23].author.orcid | https://orcid.org/0000-0002-0774-7700 |
| authorships[23].author.display_name | Patrick Y. Wen |
| authorships[23].author_position | last |
| authorships[23].raw_author_name | Patrick Y. Wen |
| authorships[23].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1158/1078-0432.22456728 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Supplemental Figure from A Multicenter, Phase II, Randomized, Noncomparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly Diagnosed Glioblastoma Patients |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11395 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9962999820709229 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2741 |
| primary_topic.subfield.display_name | Radiology, Nuclear Medicine and Imaging |
| primary_topic.display_name | Radiopharmaceutical Chemistry and Applications |
| related_works | https://openalex.org/W2497183490, https://openalex.org/W2990424668, https://openalex.org/W2078219238, https://openalex.org/W2121585125, https://openalex.org/W2123133319, https://openalex.org/W2770147923, https://openalex.org/W2141499370, https://openalex.org/W2883045718, https://openalex.org/W2279599902, https://openalex.org/W2081797247 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.1158/1078-0432.22456728 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.1158/1078-0432.22456728 |
| primary_location.id | doi:10.1158/1078-0432.22456728 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.1158/1078-0432.22456728 |
| publication_date | 2023-03-31 |
| publication_year | 2023 |
| referenced_works_count | 0 |
| abstract_inverted_index.of | 5 |
| abstract_inverted_index.Mean | 2 |
| abstract_inverted_index.plasma | 3 |
| abstract_inverted_index.Figure: | 1 |
| abstract_inverted_index.concentrations | 4 |
| abstract_inverted_index.<p>Supplemental | 0 |
| abstract_inverted_index.vandetanib.</p> | 6 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 24 |
| citation_normalized_percentile.value | 0.10416348 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |